Preparation of anionic poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) copolymeric nanoparticles as basic protein antigen carrier

Growth Factors

Volumn 25, Issue 3, 2007, Pages 202-208

  Gou, Ma Ling ^a   Huang, Mei Juan ^a   Qian, Zhi Yong ^a   Yang, Li ^a   Dai, Mei ^a   Li, Xing Yi ^a   Wang, Ke ^a   Wen, Yan Jun ^a   Li, Jiong ^a   Zhao, Xia ^b   Wei, Yu Quan ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Anionic nanoparticles; Basic fibroblast growth factor (bFGF); Electrostatic interaction; Emulsion solvent evaporation; Poly( caprolactone) poly(ethylene glycol) poly( caprolactone); Vaccine

Indexed keywords

ANION; BASIC FIBROBLAST GROWTH FACTOR; BASIC PROTEIN; COPOLYMER; DRUG CARRIER; MACROGOL 4000; NANOPARTICLE; POLYCAPROLACTONE;

ABSORPTION; ANIMAL EXPERIMENT; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; ELECTRICITY; EMULSION; ENCAPSULATION; EVAPORATION; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE PROPERTY; ZETA POTENTIAL;

ANIMALS; ANIONS; ANTIBODY FORMATION; ANTIGENS; CELL LINE; DRUG CARRIERS; ELECTROSTATICS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; MICE; MICE, INBRED C57BL; NANOPARTICLES; PARTICLE SIZE; POLYESTERS; POLYETHYLENE GLYCOLS;

ANIMALIA;

EID: 36749099493     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.1080/08977190701671613     Document Type: Article

References (24)

1. Ataman-Önal, Y., Munier, S., Ganée, A., Terrat, C., Durand, PY, Battail, N., Martinon, F., Grand, RL, Charles, MH, Delair, T. and Verrier, B. (2006) Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models. J Control Rel, 112, pp. 175-185.
2. Bartus, RT, Tracy, MA and Emerich, DF (1998) Sustained delivery of proteins for novel therapeutic agents. Science, 281, pp. 1161-1162.
3. Bilati, U., Alle'mann, E. and Doelker, E. (2005) Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. Eur J Pharm Biopharm, 59, pp. 375-388.
4. Chesko, J., Kazzaz, J., Ugozzoli, M., O'Hagan, DT and Singh, M. (2005) An investigation of the factors controlling the adsorption of protein antigens to anionic PLG microparticles. J Pharm Sci, 94, pp. 2510-2519.
5. Couvreura, P., Blanco-Prietoa, MJ, Puisieuxa, F., Roquesb, B. and Fattal, E. (1997) Multiple emulsion technology for the design of microspheres containing peptides and oligopeptides. Adv Drug Delivery Rev, 28, pp. 85-96.
6. Cui, ZR and Mumper, RJ (2002) Coating of cationized protein on engineered nanoparticles results in enhanced immune responses. Int J Pharm, 238, pp. 229-239.
7. Fu, K., Klibanov, AM and Langer, R. (2000) Protein stability in controlled-release systems. Nat Biotechnol, 18, pp. 24-25.
8. Hongkee, S. (1999) Protein behavior at the water/methylene chloride interface. J Pharm Sci, 88, pp. 1320-1325.
9. Hrkach, JS, Peracchia, MT, Domb, A., Lotan, N. and Langer, R. (1997) Nanotechnology for biomaterials engineering: Structural characterization of amphiphilic polymeric nanoparticles by 1H NMR spectroscopy. Biomaterials, 18, pp. 27-34.
10. Huang, MJ, Gou, ML, Qian, ZY, Dai, M., Li, XY, Huang, AL and Wei, YQ One-step preparation of poly(e-caprolactone)-poly(ethylene glycol)-poly(e-caprolactone) nanoparticles for plasmid DNA delivery. J Biomed Mater Res, Part A
11. Jung, T., Kamm, W., Breitenbach, A., Hungerer, KD, Hundt, E. and Kissel, T. (2001) Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-clycolide): Evaluation of antibody response after oral and nasal application in mice. Pharm Res, 18, pp. 352-360.
12. Kazzaz, J., Neidleman, J., Singh, M., Ott, G. and O'Hagan, DT (2000) Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1. J Control Rel, 67, pp. 347-356.
13. Langer, R. and Folkman, J. (1976) Polymers for the sustained release of proteins and other macromolecules. Nature, 263, pp. 797-800.
14. Liu, JY, Wei, YQ, Yang, L., Zhao, X., Tian, L., Hou, JM and Ting, N. (2003) Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2. Blood, 102, pp. 1815-1823.
15. Moghimi, S Moein, Hunter, A Christy and Murray, JC (2005) Nanomedicine: Current status and future prospects. FASEB J, 19, pp. 311-330.
16. Nimesh, S., Goyal, A., Pawar, V., Jayaraman, S., Kumar, P., Chandra, R., Singh, Y. and Gupta, KC (2006) Polyethylenimine nanoparticles as efficient transfecting agents for mammalian cells. J Control Rel, 110, pp. 457-468.
17. O'Donnell, PB and McGinity, JW (1997) Preparation of microspheres by the solvent evaporation technique. Adv Drug Delivery Rev, 28, pp. 25-42.
18. Piao, L., Dai, ZL, Deng, MX, Chen, XS and Jing, XB (2003) Synthesis and characterization of PCL/PEG/PCL triblock copolymers by using calcium catalyst. Polymer, 44, pp. 2025-2031.
19. Plum, SM, Holaday, JW, Ruiz, A., Madsen, JW, Fogler, WE and Fortier, AH (2000) Administration of a liposomal FGF-2 peptide vaccine leads to abrogation of FGF-2-mediated angiogenesis and tumor development. Vaccine, 19, pp. 1294-1303.
20. Shakesheff, KM, Evora, C., Soriano, I. and Langer, R. (1997) The adsorption of poly(vinyl alcohol) to biodegradable microparticles studied by X-ray photoelectron spectroscopy (XPS). J Colloid Interface Sci, 185, pp. 538-547.
21. Singh, M. and O'Hagan, D. (1999) Advances in vaccine adjuvants. Nat Biotechnol, 17, pp. 1075-1081.
22. Singh, M., Briones, M., Ott, G. and O'Hagan, DT (2000) Cationic microparticles: A potent delivery system for DNA vaccines. Proc Natl Acad Sci USA, 97, pp. 811-816.
23. Wei, YQ, Huang, MJ, Yang, L., Zhao, X. and Tian, L. (2001) Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen. Proc Natl Acad Sci USA, pp. 11545-11550.
24. Weich, HA, Iberg, N., Klagsbrun, M. and Folkman, J. (1990) Expression of acidic and basic fibroblast growth factors in human and bovine vascular smooth muscle cells. Growth Factors, 2, pp. 313-320.